Lpath, Inc. - Strategic Analysis Review

Summary

Lpath, Inc. - Strategic Analysis Review

Lpath, Inc. (Lpath) is a developmental stage biotechnology company engaged in discovery and development of bio-active lipid based therapeutics to treat human diseases. The company's product candidate include, Asonep a humanized monoclonal antibody for the treatment of Multiple sclerosis and cancers, iSONEP has exhibited anti-angiogenesis, anti-inflammatory, and anti-vascular permeability properties and Lpathomab which shows activity against the promoter of cancer-cell growth and metastasis. The company is headquartered in San Diego, United State

Global Markets Direct's Lpath, Inc. - Strategic Analysis Review is an in-depth business and strategic analysis of Lpath, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic and operational performance.

Contents

• List of Tables
  • Lpath, Inc. - Business Description
  • Lpath, Inc. - Major Products and Services
  • Lpath, Inc. - History
  • Lpath, Inc. - SWOT Analysis
  • SWOT Analysis - Overview
  • Lpath, Inc. - Strengths
  • Strength - Unique Technoloy Platform
  • Strength - Intellectual Property
  • Lpath, Inc. - Weaknesses
  • Weakness - Continued Losses
  • Weakness - Lack of In-House Manufacturing Facilities
  • Lpath, Inc. - Opportunities
  • Opportunity - Collaboration with Merck for ASONEP
  • Opportunity - Growth in the Prevalence of Cancer
  • Opportunity - Changing Demographics
  • Lpath, Inc. - Threats
  • Threat - Tightening of the FDA's Regulatory Oversight
  • Threat - Intense Competition
  • Threat - Impact of the Financial Crisis
  • Lpath, Inc. - Key Competitors
  • Lpath, Inc. - Key Employees
  • Lpath, Inc. - Key Employee Biographies
  • Lpath, Inc. - Company Statement
  • Lpath, Inc. - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
• Appendix
  • Methodology
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Lpath, Inc., Key Employees
  • Lpath, Inc., Major Products and Services
  • Lpath, Inc., History
  • Lpath, Inc., Key Employees
  • Lpath, Inc., Key Employee Biographies
  • Lpath, Inc., Subsidiaries